The Biospecimen and Biostatistics Core, directed by Dr. Joanna Phillips, will provide the leadership and expertise needed to support the laboratory and clinical research of the 3 Projects in this POl grant. The decision to create a single Core covering these two areas reflects the need for using sophisticated approaches to evaluate the histological and genomic properties of tissue samples, as well to understand how to combine the complex, multi-parametric data obtained with the results from in vivo imaging data. The Biospecimen component will be led by Dr. Phillips, who will interact on an ongoing basis with the leaders of each Project to ensure that the acquisition distribution, and analysis of biospecimens meets the needs of the Projects. The following resources and services will be provided: the staff and expertise to collect, process, and archive image guided brain tumor samples and fresh brain tumor tissue;morphologic and relevant molecular analysis required by the Projects;neuropathologic expertise for interpretation of the processed tissue sections and extraction of appropriate quantitative parameters or ordinal scores;a tissue inventory and a database of associated molecular parameters that can be linked to the imaging and clinical databases;and stringent compliance with regulations governing informed consent and patient confidentiality, as well as management of the biospecimens and the information derived from the biospecimens. The Biostatistical component will be led by Dr. Molinaro, who will interact on an ongoing basis with the individual leaders from all three Projects to assess their statistical needs. Services will include: advice on the design of experimental and clinical studies, including calculating sample sizes and power;data analysis support (either by performing the analyses within the core or advising qualified personnel within the projects), developing appropriate statistical models and selecting tests of significance;and, when necessary, the development of novel methods to help interpret experimental results. Dr.Molinaro and her colleagues will participate in regularly scheduled project meetings to provide input on statistical and bioinformatics techniques, as well as assisting in the preparation of material for presentation and publication.

Public Health Relevance

The Brain Tumor Biospecimen and Biostatistics Core is dedicated to the acquisition and analysis of human and animal brain tumor biospecimens. The integration of sophisticated imaging, clinical, morphometric, and genomic/epigenomic data from brain tumor samples is essential to meet the high impact translational goals of each Project. This Core will interact synergistically with the Administrative/Clinical Core as well as the Imaging Core to enhance the conduct and analyses of the reseach efforts of the projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA118816-07
Application #
8738074
Study Section
Special Emphasis Panel (ZCA1-RPRB-2)
Project Start
2014-08-01
Project End
2018-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
7
Fiscal Year
2014
Total Cost
$341,630
Indirect Cost
$125,096
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mancini, Andrew; Xavier-Magalhães, Ana; Woods, Wendy S et al. (2018) Disruption of the ?1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. Cancer Cell 34:513-528.e8
Vareth, Maryam; Lupo, Janine; Larson, Peder et al. (2018) A comparison of coil combination strategies in 3D multi-channel MRSI reconstruction for patients with brain tumors. NMR Biomed 31:e3929
Li, Yan; Lafontaine, Marisa; Chang, Susan et al. (2018) Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma. ACS Chem Neurosci 9:130-137
Gordon, Jeremy W; Chen, Hsin-Yu; Autry, Adam et al. (2018) Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients. Magn Reson Med :
Choi, Serah; Yu, Yao; Grimmer, Matthew R et al. (2018) Temozolomide-associated hypermutation in gliomas. Neuro Oncol 20:1300-1309
Park, Ilwoo; Larson, Peder E Z; Gordon, Jeremy W et al. (2018) Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med 80:864-873
Hayes, Josie; Yu, Yao; Jalbert, Llewellyn E et al. (2018) Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol 20:632-641
Zhang, Chenan; de Smith, Adam J; Smirnov, Ivan V et al. (2017) Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma. J Neurooncol 135:237-244
Autry, Adam; Phillips, Joanna J; Maleschlijski, Stojan et al. (2017) Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol 10:895-903
Anwar, Mekhail; Molinaro, Annette M; Morin, Olivier et al. (2017) Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiat Res 188:303-313

Showing the most recent 10 out of 75 publications